NEW YORK, Feb 7 – Informax said Wednesday its fourth quarter revenues jumped 59 percent to $5.8 million, compared with $3.6 million in the corresponding period in 1999, as the company added six new customers for Genomax.

For 2000, Informax’ revenues were up 71 percent, to $17.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.